American Association for Cancer Research

2006 AACR Minority Scholars in Cancer Research

2006 Minority Scholars in Cancer Research

Ayoola A. Aboyade-Cole, B.S., Florida Agricultural and Mechanical University, Tallahassee, FL. Abstract #1549. Diallyl sulfide attenuates PhIP-induces cell cycle changes and cell death in MCF-10A cells.

“I will strive to become a prominent and distinguished researcher in chemoprevention with notable contributions to the eradication of breast cancer.”

April J. Adams, B.A., University of Alabama, Birmingham, AL. Abstract #5491. Fc receptors (FcR) on the surface of human breast cancer cells may facilitate the cytotoxic effects of hTRA-8, a new humanized apoptosis-inducing antibody.

“My main long-term academic goals are to successfully complete my Ph.D. program, to gain research experience at an international level and to write a grant application that receives funding.”

Olulanu H. Aina, D.V.M., University of California, Davis, Sacramento, CA. Abstract #1126. Novel integrin binding peptides in cancer therapy.

“My long-term career goal is to become an independent and successful cancer research scientist. I hope to integrate my professional training as a DVM and my pathology training in graduate school with the current research on experimental therapeutics.”

Tunde O. Akinyeke, B.S., Meharry Medical College, Nashville, TN.

“My main career objective is to have my own laboratory at an institution that will allow me to have the scientific freedom to pursue my research in a way I feel fit.”

Keith D. Amos, M.D., UT M.D. Anderson Cancer Center, Houston, TX. Abstract #1679. Pancreatic stellate cells promote malignant potential in pancreatic cancer.

“My long-term translational research interest is to study tumor-stromal interactions in pancreatic and endocrine cancers.”

Omari J. Bandele, B.S., Vanderbilt University School of Medicine, Nashville, TN. Abstract #5536. Bioflavonoids as poisons of human topoisomerase II.

“My career goals are to obtain my doctorate degree in biochemistry and to pursue postdoctoral training in the field of environmental carcinogenesis.”

Yasmeen M. Barnes-Nkrumah, B.S., Florida Agricultural and Mechanical University, Tallahassee, FL. Abstract #1909. Diallyl sulfide inhibits 2,2’4,4’-tetra brominated biphenyl ether (BDE-47) induced DNA strand breaks and cell proliferation in MCF10A breast epithelial cells.

“My ultimate goal is to have a laboratory/firm with environmental researchers and environmental lawyers working together on research and policy of environmental pollutants.”

Max A. Benavides, M.D., Fox Chase Cancer Center, Philadelphia, PA. Abstract #2639. Methionine inhibits cellular growth dependent upon the p53 status of cell.

“My work in the field and in private practice motivates my research, putting a human face on the suffering caused by disease and underlining the necessity of making progress towards a cure.”

Yira Bermudez, M.B.A., University of South Florida College of Medicine, Tampa, FL. Abstract # 4996. Lysophosphatidic acid/vascular endothelial growth factor autocrine loop regulates ovarian cancer telomerase.

“I would like to obtain a post-doctoral position where I can continue fortifying my research skills and techniques.”

Kelly N. Blehm, B.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #4133. Mutations within the kinase domain and truncations of EGFR are rare events in urothelial carcinoma.

“I plan to focus on patient counseling as well as determining the presence of germ line mutations that result in familial breast cancer.”

Marianela Candolfi, Ph.D., D.V.M., Cedars-Sinai Medical Center, Los Angeles, CA. Abstract #2733. Glioblastoma multiforme (GBM): a comparative histological analysis of gliomas in mice, rats, dogs and humans.

“My long-term career goals are to direct my own research group and to mentor doctoral students as well as postdoctoral fellows.”

Marie C. Chia, M.S., Ontario Cancer Institute, Toronto, Ontario, Canada. Abstract #823. Radiation and Cisplatin activation of EBV in nasopharyngeal cancer: Understanding the oncolytic potential of EBV.

“My career goal is to become an independent investigator contributing to cancer research in conjunction with teaching responsibilities at an academic institution. In addition, I would like to be continually involved in health advocacy and issues in community care.”

Leah M. Cook, University of Alabama, Birmingham, AL. Abstract #2261. Resveratrol in the diet regulates IGF-1 signaling proteins in the prostate of rats.

“I would like to pursue a Ph.D. in pharmacology using the TRAMP model to study the effects of a proposed typical African-American diet in combination with some of the chemopreventive dietary polyphenols previously investigated in my other studies.”

Xochitl Cortez-Gonzalez, B.S., University of California at San Diego, San Diego, CA. Abstract #2888. Identification of immunogenic HLA-B7 restricted human telomerase reverse transcriptase peptides.

“My future goal is to pursue my scientific career in academia and ultimately to become a professor.”

Zobeida Cruz-Monserrate, B.S., University of Texas Medical Branch, Galveston, TX. Abstract #1430. Altered expression of integrin a6ß4 as a marker to distinguish pancreatic cancer from chronic pancreatitis.

“One day, I would like to look back and see that my research has contributed to cure or help improve the quality of life for individuals.”

Stephanie T. Dance, M.S., Wake Forest University School of Medicine, Winston-Salem, NC. Abstract #1469. Tumor promotion as a target for chemoprevention of lung cancer.

“After completion of my postdoctoral training, my long term career goal is to establish myself as an independent research scientist at a major university where I can devote the majority of my time to research and training graduate students.”

Tracy R. Daniels, Ph.D., University of California at Los Angeles, Los Angeles, CA. Abstract #5461. Conjugation of an anti-TfR IgG3-Avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.

“My ultimate goal is to develop a novel therapeutic that gains FDA approval and is actually used in the clinic to help patients battle their disease.”

William R. Davidson, M.S., Thomas Jefferson University, Philadelphia, PA. Abstract #5181. Off-target effects of the p53 inhibitor Pifithrin-a related to inhibition of p73 in zebrafish embryos.

“My career objectives are to maintain a principle investigator position in translational cancer research and to teach science to students of cancer and biomedical research.”

Danyetta D. Davis, M.S., Ohio State University, Columbus, OH. Abstract #4927. A novel series of bioactive-2', 4', 7'-trisubstituted isoflavones induce G0-G1 arrest and apoptosis in hormone-dependent and hormone-independent breast cancer cells.

“Throughout my career, I plan to continue my role in mentoring minority students who express an interest in science and to serve as a role model in my field.”

Edgar S. Diaz-Cruz, Ph.D., Georgetown University Lombardi Cancer Research Center, Washington, DC. Abstract #2088. The effect of the PPAR? ligand rosiglitazone on BRCA1 gene expression in mice.

“I would like to work for an institution that allows me to develop my own research project in the area of translational breast cancer research with an emphasis on drug development.”

Chevonne D. Eversley, B.S., University of North Carolina, Chapel Hill, NC. Abstract #5100. Identifying resistance modifiers of azoxymethane induced colon cancer.

“I hope to use this scientific knowledge that I am gaining to help further my education, research and career goals.”

Tyesha L. Farmer, B.S., University of Alabama, Birmingham, AL.

“My ultimate career goal is to become full Professor of Genetics and Principal Investigator within academia.”

LaNeisha B. Farrar, B.S., North Carolina Central University, Durham, AL. Abstract #116. The Regulation of the UDP-glucuronosyltransferase 2B28 gene by glucocorticoids and epidermal growth factor.

“My long-term research goal is to understand the role of UGT2B28 expression in the onset of prostate cancer.”

Celia Garcia-Prieto, M.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #4702. OSW-1 induces calcium-dependent apoptosis: Involvement of mitochondria and endoplasmic reticulum.

“My future plans include becoming a professor in an academic institution where I can establish a very active cancer research program and establish programs that help expose minority groups to scientific research.”

Valerie Stone Hawthorne, B.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #4099. Transcriptional upregulation of p21Cip1 by ErbB2 overexpression through STAT3 activation.

“I have decided to devote my future career to the better understanding of breast cancer and to aid those who suffer from this devastating disease.”

Latorya D. Hicks, Ph.D., St. Jude Children's Research Hospital, Memphis, TN. Abstract #5530. Synthesis of novel benzils and benzoins as selective inhibitors of mammalian carboxylesterases designed to ameliorate the delayed diarrhea associated with CPT-11 treatment.

“As an underrepresented minority scientist in biomedical sciences as well as a woman, it has been and continues to be my goal to receive quality scientific training that would best equip me to be a reputable scientist but also to become a mentor/advisor to other young scientists.”

Janell G. Hill, B.S., Howard University College of Medicine, Washington, DC. Abstract #2974. Variations in CHEK2 in high-risk African American families.

“My long- term goals are centered around the mission of Howard University College of Medicine, to serve the underserved populations of this country.”

Titilope A. Ishola, B.S., University of Texas Medical Branch, Galveston, TX.

“Overall, my goal is to acquire the essential skills needed to become a well-rounded, successful investigator. This will allow me to be a significant contributor to the scientific community and also offer me the opportunity to mentor other students as they strive to achieve their goals.”

Erica L. Johnson, B.S., Morehouse School of Medicine, Atlanta, GA. Abstract #299. CCL25-CCR9 axis role in ovarian cancer cell metastasis and survival.

“After I have gained the knowledge, experience, and expertise needed, the next step in my journey is to become an investigator within the National Institutes of Health.”

Crystal M. Johnson-Holiday, B.S., Morehouse School of Medicine, Atlanta, GA. Abstract #292. CCR9-mediated breast carcinoma motility, invasion, and MMP expression.

“I would like to utilize the background I have in pharmaceutical science to further an understanding of the underlying mechanisms of the immune system’s role in cancer metastasis.”

Larry E. Jones, Jr., B.S., University of South Carolina, Columbia, SC. Abstract #3549. Nitric oxide-induced post-translational modification and the activity of human N-methylpurine DNA glycosylase.

“The determination to succeed and to significantly contribute to humanity is what motivates me to become a professor of biomedical research.”

Kathie-Ann P. Joseph, M.D., Columbia University Medical Center, New York, NY. Abstract #4624. Combined soluble receptor for advanced glycation endproducts (sRAGE) with cytotoxic chemotherapy effectively reduces metastatic tumor growth in a spontaneous mammary tumor model through modulation of cell proliferation and apoptosis.

“I plan to further pursue an academic career as a physician scientist. My clinical practice and community outreach endeavors only inspire me further in treating breast cancer in the lab.”

Everardo Macias, B.S., North Carolina State University, Raleigh, NC. Abstract #3198. Transgenic expression of CDK4 and CDK2 in mouse embryonic oral cavity is specifically retained in the adult adenohypophysis and collaborates in pituitary tumorigenesis.

“My long-range educational goals include finishing my doctorate and obtaining experience via post-doctoral training.”

Salamatu S. Mambula, Ph.D., Beth Israel Deaconess Medical Center, Boston, MA. Abstract #3878. Lysosomal exocytosis: a mechanism for hyperthermia-induced HSP70 release from prostate cancer cells.

“My career goal is to become an independent investigator in an academic institution in the field of cancer biology due to my life-long curiosity and training in biological phenomena.”

Magaly Martinez-Ferrer, Ph.D., Vanderbilt University School of Medicine, Nashville, TN. Abstract #2526. a2ß1 integrin and mammary gland development.

“My research objectives are to determine the role in vivo of the ?2?1 integrin in the mammary gland development and the role of altered ?2?1 integrin expression on breast cancer development, cancer phenotype and tumor progression.”

Corina Marx, Ph.D., Buck Institute for Age Research, Novato, CA. Abstract #5616. Therapeutic destabilization of ErbB2 transcripts mediated by U-rich mRNA binding proteins and microRNAs.

“I plan to continue to build a career as a researcher in oncology. I will work towards my goal of becoming an independent investigator in an academic setting, where I can apply the expertise and knowledge I have gained to teach, mentor and guide young scientists.”

Michael L. McCaskill, M.P.H., Florida Agricultural and Mechanical University, Tallahassee, FL. Abstract #1892. The inhibition of diethylstilbestrol induced DNA strand breaks and lipid peroxidation by diallyl sulfide in MCF10A cells via the induction of superoxide dismutase.

“I would be pleased by the opportunity to educate students at the university level to help groom future scientist as I am being groomed.”

Arlixer M. McGhee, M.S., University of Louisville, Louisville, KY.

“As an African-American female, I feel obligated to bridge the disparity gap. I plan to be an advocate for increasing minority participation in healthcare and medical research through recruitment of minority participants in research trials.”

Robert J. McKallip, Ph.D., University of South Carolina School of Medicine, Columbia, SC. Abstract #4617. Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22 phox and Nox4 expression.

“In the future, I hope to further enhance my teaching skills and I am excited about the possibility of participating in teaching and training medical and graduate students at the University of South Carolina.”

Lisa A. McPhatter, M.S., Duke University Medical Center, Durham, NC. Abstract #5707. Combination therapy of bevacizumab with rapamycin in antitumor activity.

“My educational/research goal encompasses a continuance in basic science research at the post doctoral level, by contributing to a research project whose goals are increasing knowledge about cancer and the mechanism of action involving anti-angiogenic therapies.”

Fayth L. Miles, M.S., University of Delaware, Newark, DE. Abstract #3429. The role of TGF-ß1 in prostate cancer progression.

“After I get my Ph.D. at University of Delaware, I plan to do a post doctoral for a few years at a university or research institute in an area relating to cancer metastasis, and establish myself as a credible independent researcher.”

Caroline N. Mills, B.S., Marshall University/Joan C. Edwards School of Medicine, Huntington, WV. Abstract #4965. Expression and function of HIF1a and its variant in human melanoma progression.

“I realize it is my responsibility to put my personal and professional skills to the benefit of the minority research community.”

Chavonda J. Mills, B.S., Florida Agricultural and Mechanical University, Tallahassee, FL. Abstract #1132. Synthesis of novel flavonoid derivatives and evaluation of their anti-cancer activities.

“My overall purpose as a medicinal chemist is to discover medicines that will have an impact on improving the quality of life for others. I know that working in cancer research will provide me this opportunity.”

Patrice E. Moss, B.S., Meharry Medical College, Nashville, TN.

“Overall, my long-term educational goal is to further my knowledge of human cancer conditions with a focus on understanding cancer biochemistry.”

Tijuana N. Moss, B.S., Texas A&M University System Health Science Center, Houston, TX. Abstract #4064. LRPPRC interactive protein UXT causes mitochondrial aggregation.

“I plan to become an asset to my community by developing and refining my laboratory skills and then applying them towards scientifically investigating health issues that tend to disproportionately affect African Americans.”

D'Anna N. Mullins, B.S., Medical University of Ohio, Toledo, OH. Abstract #140. CEBPG transcription factor correlation with antioxidant and DNA repair genes in normal bronchial epithelial cells of individuals with and without bronchogenic carcinoma.

“My long-term educational and research training goal is to apply to a residency program that has a strong research component or a residency/postdoctoral component.”

Lisandra Negrón-Vega, B.S., University of Puerto Rico, San Juan, PR. Abstract #74. The expression of a soluble isoform of EGFR (p110 sEGFR) is regulated at the transcriptional level in breast adenocarcinoma cell lines.

“My long- term goal is be part of the academy as a professor and to become an independent investigator. I would like to contribute to the understanding of biochemistry cancer that might lead to the development of novel cancer therapies.”

Oneil G. Newell, B.S., Florida Agricultural and Mechanical University, Tallahassee, FL. Abstract #5604. Diallyl sulfide inhibits lipid peroxidation while inducing CYP 1A1 in the liver of male Sprague Dawley rats.

“My research includes investigating and elucidating mechanisms of environmental and chemical carcinogens as well as looking at the chemopreventive properties of Diallyl Sulfide.”

Stephanie C. Nnadi, B.A., Thomas Jefferson University, Philadelphia, PA.

“No matter where my investigations take me, I am first and foremost committed to research that will aid in the development of treatments that will improve the quality of life for patients suffering from inherited disease.”

Onyinye F. Nwagbara, M.S., Florida Agricultural and Mechanical University, Tallahassee, FL. Abstract #1083. Induction of p53 expression, cell death, and DNA strands breaks by benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE) in PC3 and DU145 prostate carcinoma cell lines.

“My career ambitions are to teach in a university, conduct scientific research, mentor and work toward sustaining and preserving our environment.”

Patrick S. O’Toole, B.S., University of Colorado Health Sciences Center, Aurora, CO. Abstract #2381. Apoptotic and non-apoptotic cell death induction by a targeted anti-cancer agent in different tumor cells.

“My long- term educational and research training goal is to become one of the best translational cancer researchers around.”

John T. Powers, B.S., UT M.D. Anderson Cancer Center, Houston, TX. Abstract #5623. E2F1 induces ATM dependent p53 phosphorylation that is independent of transcription and DNA damage.

“My graduate research has been primarily focused on a key cell cycle regulating transcription factor. I am fortunate enough to have made several published contributions to my field.”

Freddie L. Pruitt, B.S., University of Delaware, Newark, DE Abstract #1349. The effect of a novel thalidomide analog, SC-2-71, on caspase activity in human bone endothelial cells.

“The future holds no limits and I want to be intimately involved in researching the molecular mechanism responsible for cancer progression that leads ultimately to more effective therapeutic strategies.”

Maria E. Ramos-Nino, Ph.D., University of Vermont, Burlington, VT. Abstract #4269. Hepatocyte Growth Factor mediates growth through the activation of ERK5 in mesothelioma cell lines.

“My long- term research goal is to understand the transcriptional and translational mechanisms of gene regulation governing tumorigenic processes, with the hope of providing information for the future development of better therapeutic strategies.”

Luisel J. Ricks-Santi, B.S., Georgetown University Medical Center, Washington, DC. Abstract #3695. Induced chromosomal aberrations, genetics, and pathology in hereditary breast cancer.

“My goal of pursuing research in molecular and genetic epidemiology and breast cancer research by providing training in tumor biology and the supportive training offered through your programs will equip me for completion of my thesis project and prepare me for further research in the field.”

Omar J. Rivera, Ph.D., University of Texas Health Science Center, San Antonio, TX. Abstract #2742. Medulloblastoma but not rhabdomyosarcoma in a conditional mouse model of Patched1 haploinsufficiency.

“My ultimate career goal is to earn a position as an independent investigator in the field of cancer research.”

Sulay Rivera-Sánchez, B.S., University of Puerto Rico, San Juan, PR. Abstract #85. Detection of p60 sEGFR by an acridinium linked immunosorbent assay (ALISA).

“My long- term goal is to work in the discovery and development of new anti-cancer drugs. In addition, I would like to participate in the education of people about cancer and its therapies.”

John A. Sandoval, M.D., Indiana University School of Medicine, Indianapolis, IN. Abstract #4342. Neuroblastoma 3D cell culture: Proteomic differences between cancer spheroids and monolayers.

“My goal is to become an independent investigator conducting research on the inner-workings of childhood neoplasm as I continue to strive towards becoming a pediatric surgeon.”

Christopher Sistrunk, M.S., North Carolina State University, Raleigh, NC. Abstract #5630. Skp2 deficiency inhibits ras-dependent tumorigenesis and myc-induced keratinocyte proliferation.

“Upon completion of my Ph.D., I would like to continue my training by pursuing a post doctorate position in the field of carcinogenesis. This additional training would give me an opportunity to learn new techniques, ideas, and it will also serve as a great way to network.”

Adrienne J. Smith, M.S., Wake Forest University, Winston-Salem, NC. Abstract #4083. Role of BAD in the proliferation of prostate cancer cells.

“I am quite interested in furthering my research in signal transduction; therefore I would prefer to obtain a postdoctoral position in this area. Once I have completed, I will pursue a teaching position in high academia.”

Michael A. Smith, B.S., Howard University, Washington, DC. Abstract #3869. Eosinophil major basic protein (MBP) and tumor necrosis factor (TNFa) inhibit prostate multicellular spheroid (MTS)growth.

“Upon completion of my doctorate degree, my goal is to incorporate the disciplines of research with medicine.”

Pameeka S. Smith, B.S., Wake Forest University, Winston-Salem, NC. Abstract #4417. Knocking down catalase leads to increased ROS production and proliferation in glioma cells.

“Upon completion of graduate school, I intend to pursue postdoctoral fellowships where I will establish and find my niche in the field of science.”

Sunyata Smith, B.S., Feinstein Institute for Medical Research, Manhasset, NY. Abstract #664. The effects of 3, 3’-diindolylmethane and genistein on estrogen induced proliferation and estrogen metabolism in human prostate cancer cell lines.

“My long-term goal career goal is to conduct clinical research in the area of immunonutrition and cancer, which holds great promise for an immunological cure for cancer.”

David R. Soto-Pantoja, B.S., Wake Forest University, Winston-Salem, NC. Abstract #950. Inhibition of angiogenesis by angiotensin-(1-7).

“I would like to be remembered as a researcher who worked tirelessly and with impassioned commitment to improve the diagnosis, treatment and prevention of cancer.”

Dominique R. Talbert, B.S., University of Kentucky, Lexington, KY. Abstract #211. Rosiglitazone Activates ERa and PPAR? Altering Their Crosstalk and Effect on Proliferation in Cancer Cells.

“Following my postdoctoral position, I plan to start my career at a leading pharmaceutical company where I will continue my research into hormonal regulation of breast cancer.”

Carmen S. Tellez, Ph.D., UT M.D. Anderson Cancer Center, Houston, TX. Abstract #6259. Quantitative analysis of melanocytic tissue array reveals inverse correlation between AP-2a and PAR-1 expression during melanoma progression. Abstract #1719. CpG island hypermethylation profile of human melanoma cell lines in relation to global methylation and mutations in BRAF and NRAS.

“To achieve my career goal of becoming a successful independent researcher, I am presently involved in developing and executing investigations that employ the strengths of my mentor and include my own research strengths and interests.”

Abeba Tesfaye, Ph.D., Johns Hopkins University School of Medicine, Baltimore, MD. Abstract #1791. HMGA1a is necessary and sufficient for uterine tumorigenesis

“My long- term goal is to become an independent investigator in the field of cancer biology at an academic institution.”

Shala L. Thomas, B.S., Emory University, Atlanta, GA Abstract #5732. Anti-HIF Activity of curcumin and analog EF24.

“My long range education and research training goal is to become an independent scientist so that I can carry out projects on my own initiative and master complex topics in cancer.”

Charles E. Thompson, III., B.S., Howard University, Washington, DC.

“After graduation from medical school, it is my plan to continue cancer research. My specific areas of interest are breast and prostate cancer.”

Lynnelle W. Thorpe, B.S., University of Delaware, Newark, DE. Abstract #3444. The characterization of CD44 and HAS in a linear human prostate cancer progression model.

“There is great importance in conducting research and having career goals, but my mission is much bigger that these two entities .The power of healing and curative measures comes through knowledge and wisdom, which leads me to another mission - teaching,”

Juan J. Toro, M.D., University of Texas Health Science Center, San Antonio, TX. Abstract #2900. Potential role of Interleukin-15 in the pathogenesis of B-cell chronic lymphocytic leukemia.

“My long- term career and research objectives include establishing myself as an independent cancer research scientist at a well-known university or cancer center and utilizing my scientific expertise to develop early detection methods for cancer and prognostic markers.”


Jose G. Treviño, M.D., University of Illinois, Chicago, IL. Abstract #4835. Interleukin-8 is regulated by a Src/STAT3 pathway in pancreatic adenocarcinoma cells that is NF-?B independent.

“My long- term educational and research goal is to establish myself as a surgeon in an academic environment where I can also perform independent research.”

Blanca L. Valle, B.S., University of Puerto Rico, San Juan, PR. Abstract #75. The proteolytic cleavage of EGFR is mediated by metalloproteases.

“As part of my goals, I am focused on finishing my research to complete my doctoral degree in biochemistry. After I finish, I plan to continue postdoctoral studies.”

Darius M. Walker, B.S., University of Colorado Health Sciences Center, Aurura, CO. Abstract #1744. Identification of ESE1 SAR-domain interacting proteins that mediate a novel cytoplasmic transformation mechanism.

“The notion of translational research appeals to both my desires- to remain immersed in science and have more of an immediate impact on the availability of cancer therapeutics and possible cures.”

Valerie G. Walker, D.V.M., West Virginia University, Morgantown, WV. Abstract #4251. PMA induces the cSrc-activating protein, AFAP-110, to colocalize with cSrc in a PI3K-dependent fashion.

“My research goals are to improve the quality and longevity of the lives of cancer patients, allowing them more time to spend with their loved ones.”

Vonetta L. Williams, M.P.H., University of South Florida, Tampa, FL.

“Research is my first career goal and I’m very fortunate to work with cancer researchers at H. Lee Moffitt Cancer Center and Research Institute. Working with the cancer researchers has afforded me the unique opportunity to see first hand what it means to do research and to see what it takes both mentally and physically to conduct epidemiologic studies among persons diagnosed with cancer.”

Chantell L. Wilson, Ph.D., Thomas Jefferson University, Philadelphia, PA.

“Ultimately, I would like to work at a university where I can teach and work in a laboratory. I would really enjoy this period of time because it will allow me to use my talents in a leadership position to further help minorities learn and use research skills.”